SSMXY logo

SSMXY Sysmex Corporation

Other OTC · Medical - Instruments & Supplies · Healthcare

$11.98
+0.14 (+1.18%)

Sysmex Corporation, headquartered in Kobe, Japan, is a prominent developer, manufacturer, and distributor of diagnostic instruments, reagents, and specialized software. The company's extensive offerings cater to diverse medical needs, including hematology, where it provides three-part and five-part white blood cell differentiation instruments, alongside high-volume testing transport systems for la…

Market Cap: $7.45Bwww.sysmex.co.jp

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

100
100
Aug 12Aug 12

Quote

Day Range
$11.98 – $12.03
52-Week Range
$8.01 – $13.49
Volume
$900.00
Market Cap
$7.45B
50-Day Avg
$9.70
200-Day Avg
$9.40
Prev Close
$11.84
Open
$12.00

Valuation & Ratios

P/E Ratio
22.71
EPS
$60.32
P/B Ratio
1.69
P/S Ratio
1.62
Debt/Equity
0.14
Current Ratio
3.26
Dividend Yield
+2.8%
Gross Margin
+51.1%

Returns & Efficiency

Return on Equity
+7.4%
Return on Assets
+5.3%
FCF Yield
+5.1%
EV/EBITDA
7.35

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2026$530.16B$37.59B$60.72
2025$508.64B$53.67B$86.07
2024$461.51B$49.64B$79.27
2023$410.50B$45.78B$72.94
2022$363.78B$44.09B$70.29

Social Signal Score

50
5d
50
1 mentions
30d
50
1 mentions
60d
50
1 mentions
90d
50
1 mentions
news: 1

Earnings

Wed, Nov 4(in 3 months)

Consensus estimate $0.11 per share

3of 7 quarters beat consensus

Typical surprise -2.0% (median, so one quarter with a near-zero estimate can't distort it)

  • Fri, Aug 7$0.09 vs $0.07beat
  • Wed, May 13$0.02 vs $0.04miss
  • Thu, Feb 12$0.15 vs $0.14beat
  • Wed, Nov 5$0.16 vs $0.16miss
  • Wed, Aug 6$0.05 vs $0.12miss
  • Wed, May 14$0.12 vs $0.16miss

Estimates and results for SSMXY via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

Project earnings forward and see what return today's price implies.

Seeded from SSMXY's reported EPS growth of -3.6% a year over 4 years.

EPS in 5 years
$50.22
Implied price
$1,155
Return from $11.98
149.4% a year

To earn 15.0% a year on these assumptions you'd need to buy at $574.26 — today's price is already 97.9% below that.

How sensitive is that answer?

Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.

growth \ P/E1720232629
-13.6%110.4%117.3%123.5%129.0%134.1%
-8.6%122.6%129.9%136.4%142.3%147.6%
-3.6%134.7%142.5%149.4%155.6%161.2%
1.4%146.9%155.1%162.3%168.8%174.7%
6.4%159.1%167.6%175.2%182.1%188.3%

This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.

Mentions (1)

  • Newsseekingalpha.com·3d ago·Neutral

    Sysmex Corporation (SSMXY) Q1 2027 Earnings Call Prepared Remarks Transcript Sysmex Corporation (SSMXY) Q1 2027 Earnings Call Prepared Remarks Transcript

    View source ↗